GlassScriptPhysician profile
Gary S Wilson
NPI 1316991920
$924.93
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $188 · 2021: $75.74 · 2022: $39.65 · 2023: $398 · 2024: $55.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $236.72 | 2019-2023 | Sapien 3 Ultra Resilia |
| Csl Behring | $204.33 | 2021-2023 | Kcentra |
| Atricure, INC. | $188.03 | 2020 | |
| Merck Sharp & Dohme LLC | $65.28 | 2021-2023 | Bridion |
| Abiomed | $55.08 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.58 | 2019 | |
| Portola Pharmaceuticals, LLC | $37.09 | 2019 | |
| Heron Therapeutics, INC. | $29.88 | 2022-2023 | Zynrelef |
| Cerus Corporation | $23.62 | 2023 | Intercept Blood System For Platelets |
| Abbott Laboratories | $23.58 | 2021 | |
| Medtronic, INC. | $17.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.